Infrequent mutation of p16INK4 in sporadic melanoma

Journal of Investigative Dermatology

Volumn 107, Issue 3, 1996, Pages 318-321

  Healy, Eugene ^a,b   Sikkink, Stephen ^a   Rees, Jonathan L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Benign melanocytic nevus; Loss of heterozygosity; Spitz nevus tumor suppressor gene

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MELANOMA; MUTATION; NEVUS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; CHROMOSOME 9; GENETICS; HETEROZYGOTE; MOLECULAR GENETICS; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SKIN TUMOR;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 9; HETEROZYGOTE; HUMANS; MELANOMA; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 0029664945     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12363118     Document Type: Article

References (37)

1. Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJS: Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 55:1351-1354, 1995
2. Blaszyk H, Hartmann A, Schroeder JJ, McGovern RM, Sommer SS, Kovach JS: Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting. Biotechniques 18:256-260, 1995
3. Brenner AJ, Aldaz CM: Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res 55:2892-2895, 1995
4. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-416, 1994
5. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8:27-32, 1994
6. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, Olopade OI, Diaz MO, Kwiatkowski DJ, Piepkorn MW, Zone JJ, Skolnick MH: Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258:1148-1152, 1992
7. Elder DE: Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 75(suppl):245-256, 1995
8. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ernstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE, Dracopoli NC: Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89:10557-10561, 1992
9. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen TD, Beart RW, Van Tornout JM, Jones PA: Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissue correlates with gene silencing. Cancer Res 55:4531-4535, 1995
10. Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR: Homozygotes for CDNK2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet 10:351-353, 1995a
11. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick MH, Cordon-Cardo C, Kamb A: Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol 146:1199-1206, 1995b
12. Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H, Rees JL: Allelotypes of primary cutaneous melanoma and benign melanocytic naevi. Cancer Res 56:589-593, 1996
13. Healy E, Rehman I, Angus B, Rees JL: Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosom Cancer 12:152-156, 1995
14. INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 84:4038-4044, 1994
15. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPJ, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530, 1995
16. Holland EA, Beaton SC, Edwards BG, Kefford RF, Mann GJ: Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene 9:1361-1365, 1994
17. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC: Germline p16 mutations in familial melanoma. Nature Genet 8:15-21, 1994
18. Isshiki K, Seng BA, Elder DE, Guerry D, Linnenbach AJ: Chromosome 9 deletion in sporadic and familial melanomas in vivo. Oncogene 9:1649-1653, 1994
19. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKW, Kinzler KW, Vogelstein B: Deletion of p16 and p156 genes in brain tumors. Cancer Res 54:6353-6358, 1994
20. INK4 gene mediated by an adenovirus vector. Cancer Res 55:3250-3253, 1995
21. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440, 1994a
22. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Mild Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 8:22-26, 1994b
23. Kanjilal S, Strom SS, Clayman GL, Weber RS, El-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML, Ananthaswamy HN: p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 55:3604-3609, 1995
24. Li FP: Molecular epidemiology of familial cancers. In: Brugge J, Curran T, Harlow E, McCormick F (eds.). Origins of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1991, pp 211-218
25. INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene 11:405-412, 1995
26. MacKie R, Hunter JA, Aitchison TC, Hole D, Mclaren K, Rankin R, Blessing K, Evans AT, Hutcheon AW, Jones DH, Soutar DS, Watson ACH, Cornbleer MA, Smyth JF: Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet 339:971-975, 1992
27. MacLennan R, Green AC, McLeod GR, Martin NG: Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84:1427-1432, 1992
28. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1:686-692, 1995
29. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54:3396-3397, 1994
30. Nancarrow DJ, Mann GJ, Holland EA, Walker GJ, Beaton SC, Walters MK, Luxford C, Palmer JM, Donald JA, Weber JL, Fountain JF, Kefford RF, Hayward NK: Confirmation of chromosome 9p linkage in familial melanoma. Am J Hum Genet 53:936-942, 1993
31. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756, 1994
32. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM, Huebner K: Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 54:5269-5272, 1994
33. Puig S, Ruiz A, Lazaro C, Castel T, Lynch M, Palou J, Vilalta A, Weissenbach J, Mascaro JM, Estivill X: Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. Am J Hum Genet 57:395-402, 1995
34. Sarkar G, Yoon HS, Sommer SS: Dideoxy fingerprinting (ddF): a rapid and efficient screen for the presence of mutations. Genomics 13:441-443, 1992
35. Spruck CH, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tsai YC, Jones PA: p16 gene in uncultured tumours. Nature 370:183-184, 1994
36. Walker GJ, Palmer JM, Walters MK, Nancarrow DJ, Parsons PG, Hayward NK: Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions. Oncogene 9:819-824, 1994
37. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M: A second-generation linkage map of the human genome. Nature 359:794-801, 1992